SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,464,095 | +62.7% | 12,078 | +48.4% | 0.17% | -8.2% |
| Q3 2022 | $900,000 | -10.6% | 8,140 | -36.8% | 0.18% | +21.3% |
| Q1 2022 | $1,007,000 | +18.5% | 12,887 | +13.0% | 0.15% | -23.5% |
| Q1 2021 | $850,000 | +92.7% | 11,400 | +293.1% | 0.20% | +115.4% |
| Q2 2019 | $441,000 | -7.7% | 2,900 | -19.8% | 0.09% | -15.7% |
| Q2 2018 | $478,000 | +116.3% | 3,615 | +21.3% | 0.11% | +92.9% |
| Q1 2018 | $221,000 | -73.2% | 2,981 | -83.6% | 0.06% | -71.6% |
| Q3 2017 | $826,000 | +301.0% | 18,200 | +198.4% | 0.20% | +159.2% |
| Q2 2017 | $206,000 | – | 6,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |